Gallagher Robyn; Belshaw Julie; Kirkness Ann; Roach Kellie; Sadler Leonie; Warrington Darrell
(Lippincott Williams & Wilkins, 2010)
Background and Research Objective: Sublingual nitroglycerin (SLNTG) medications are a recommended treatment for people with coronary artery disease (CAD); however, prescription and knowledge may be suboptimal. This study ...